03Sep/13

More data backs Novartis' serelaxin in heart failure – PMLiVE

Organ Failure

Business Recorder

More data backs Novartis’ serelaxin in heart failure
PMLiVE
Momentum continues to build behind Novartis’ heart failure candidate serelaxin, with new data from the European Society of Cardiology (ESC) meeting cementing its position as a blockbuster-in-waiting. A new analysis of data from the RELAX-AHF study has …
Novartis heart failure drug effective across patient groupsReuters India
Novartis’ serelaxin (RLX030) improved symptoms and mortality across multiple …ITNews
Efficacy Of Novartis AG (ADR) (NYSE:NVS) For Heart FailuresPR Carbon (press release)

all 10 news articles »
03Sep/13

SERVE-HF; the World's Largest Study of Sleep-Disordered Breathing in Heart … – PR Newswire (press release)

Organ Failure

SERVE-HF; the World’s Largest Study of Sleep-Disordered Breathing in Heart …
PR Newswire (press release)
Approximately 14 million people in Europe are living with heart failure2 and central sleep-disordered breathing is known to be a highly prevalent comorbidity in these patients. With an estimated 30-50 percent of heart failure patients potentially at …

and more »
03Sep/13

Hot Line IV: Late-breaking trials on heart failure and acute coronary syndrome – EurekAlert (press release)

Organ Failure

Hot Line IV: Late-breaking trials on heart failure and acute coronary syndrome
EurekAlert (press release)
AMSTERDAM, The Netherlands – The blood pressure lowering drug aliskiren did not improve coronary artery disease when given to patients who had prehypertension, results of the Aliskiren Quantitative Atherosclerosis Regression Intravascular Ultrasound …

and more »
02Sep/13

RESEARCH AND MARKETS: Acute Heart Failure – Pipeline Review, H2 2013 … – 4-traders (press release)

Organ Failure

RESEARCH AND MARKETS: Acute Heart Failure – Pipeline Review, H2 2013 …
4-traders (press release)
Global Markets Direct’s, ‘Acute Heart Failure – Pipeline Review, H2 2013′, provides an overview of the indication’s therapeutic pipeline. This report provides information on the therapeutic development for Acute Heart Failure, complete with latest …

and more »